The Canadian Cancer Clinical Trials Network (3CTN)

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve recruitment and the efficiency and quality of academic cancer clinical trials in Canada.

Our Impact at a Glance

What we achieved in 2018-2019:

223

Portfolio trials supported

4172

patients recruited to portfolio trials

72%

increase in patients above the pre-3CTN baseline

How We Deliver Impact

The 3CTN framework supports member cancer centres conducting research across the Network and engages patient voices at every step.

Stay Connected

Our Partners

Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.

Funding Partners

Collaborators